Lisata Therapeutics Inc (LSTA) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,89%	1 083,04	−9,76	−0,89%	—	1 092,80	1 093,68	1 094,85	1 081,97	—	—
SIXC Communications SIXC Communications	SIXC −0,39%	602,38	−2,36	−0,39%	—	604,74	604,74	605,10	601,34	—	—
SIXE Energy SIXE Energy	SIXE +2,31%	1 242,83	+28,03	+2,31%	—	1 214,80	1 220,81	1 243,82	1 220,81	—	—
SIXI Industrials SIXI Industrials	SIXI −0,62%	1 713,82	−10,75	−0,62%	—	1 724,57	1 727,02	1 732,30	1 707,43	—	—
SIXM Financials SIXM Financials	SIXM +0,09%	639,99	+0,56	+0,09%	—	639,43	641,58	644,53	637,50	—	—
SIXR Staples SIXR Staples	SIXR −0,20%	837,46	−1,69	−0,20%	—	839,15	836,90	840,48	832,89	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,65%	214,22	−1,40	−0,65%	—	215,62	215,62	216,21	213,48	—	—
SIXT Technology SIXT Technology	SIXT +0,78%	3 204,38	+24,86	+0,78%	—	3 179,52	3 191,50	3 205,09	3 177,75	—	—
SIXU Utilities SIXU Utilities	SIXU −1,23%	925,38	−11,53	−1,23%	—	936,91	935,42	937,17	923,20	—	—
SIXV Health care SIXV Health care	SIXV −0,69%	1 442,71	−10,06	−0,69%	—	1 452,77	1 445,93	1 447,43	1 434,91	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,16%	2 361,34	−3,84	−0,16%	—	2 365,18	2 353,64	2 368,10	2 347,80	—	—

LSTA:NASDAQ

Lisata Therapeutics Inc

3,22 USD

+0,62%

(+0,020) 1 D

29. apr., 16:00:00 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for LSTA …

Åpne

3,18 USD

Høy

3,25 USD

Lav

3,12 USD

Markedsverdi

29,08 mill.

Snittvolum

84,13k

Volum

61,73k

52 u høy

5,07 USD

52 u lav

1,81 USD

EPS

−1,91 USD

Beta

1,10

Utestående aksjer

9,03 mill.

Antall ansatte

Relaterte aksjer

CBL International Ltd

0,48 USD

+6,02%

JFB

JFB Construction Holdings

5,79 USD

−1,03%

LZMH

LZ Technology Holdings Ltd

0,11 USD

+7,00%

Nyhetssaker

Fra kilder på nettet

Simply Wall Street

for 2 minutter siden

Omnicell (OMCL) Q1 EPS Recovery Tests Bullish Margin Improvement Narrative

Stocktwits

for 15 minutter siden

S&P 500, Nasdaq Futures Climb After Mag 7 Earnings Kickoff: MSFT, META, AMZN, GOOG, INTC Stocks In Focus

Simply Wall Street

for 39 minutter siden

Ionis Pharmaceuticals (IONS) Trailing US$381.4m Loss Tests Bullish Profitability Narratives Ahead Of Q1 2026

Simply Wall Street

for 1 time siden

Is Caesars Entertainment (CZR) Offering A Chance After Mixed Long Term Returns?

Profil

Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022. In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia

Om Lisata Therapeutics Inc

Administrerende direktør-

Ansatte21

Grunnlagt1980

HovedkontorBasking Ridge, New Jersey, USA

Sektor-

Nettstedlisata.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	-	70,00k	-	100,00k
Varekostnad	-	-	-	-
Direkte driftskostnader	-	-	-	-
Utgifter til forskning og utvikling	2,60 mill.	2,25 mill.	1,96 mill.	1,13 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	3,24 mill.	2,68 mill.	2,46 mill.	2,04 mill.
Driftskostnader	5,85 mill.	4,94 mill.	4,41 mill.	3,18 mill.
Totale driftskostnader	5,85 mill.	4,94 mill.	4,41 mill.	3,18 mill.
Driftsinntekter	−5,85 mill.	−4,87 mill.	−4,41 mill.	−3,08 mill.
Andre ikke-operasjonelle inntekter	−105,00k	−7,00k	−18,00k	−16,00k
EBT inkludert uvanlige elementer	−5,69 mill.	−4,66 mill.	−4,25 mill.	−2,95 mill.
EBT uten uvanlige elementer	−5,69 mill.	−4,66 mill.	−4,25 mill.	−2,95 mill.
Kostnad for inntektsskatt	−962,00k	-	-	-
Faktisk avgiftssats	16,92 %	-	-	-
Andre driftskostnader	-	-	-	-
Nettoinntekt	−4,72 mill.	−4,66 mill.	−4,25 mill.	−2,95 mill.
Netto fortjenestemargin	-	−6 655,71 %	-	−2 954,00 %
Resultat per aksje	−0,55	−0,54	−0,49	-
Rente- og investeringsinntekter	266,00k	216,00k	183,00k	141,00k
Rentekostnader	-	-	-	-
Netto rentekostnader	266,00k	216,00k	183,00k	141,00k
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	−5,80 mill.	−4,82 mill.	−4,37 mill.	−3,06 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning